The prion hypothesis: from biological anomaly to basic regulatory mechanism

Prions are unusual proteinaceous infectious agents that are typically associated with a class of fatal degenerative diseases of the mammalian brain. However, the discovery of fungal prions, which are not associated with disease, suggests that we must now consider the effect of these factors on basic cellular physiology in a different light. Fungal prions are epigenetic determinants that can alter a range of cellular processes, including metabolism and gene expression pathways, and these changes can lead to a range of prion-associated phenotypes. The mechanistic similarities between prion propagation in mammals and fungi suggest that prions are not a biological anomaly but instead could be a newly appreciated and perhaps ubiquitous regulatory mechanism.

[1]  M. Bruce,et al.  Scrapie strain variation and mutation. , 1993, British medical bulletin.

[2]  R. Parker,et al.  Genetic interactions between [PSI+] and nonstop mRNA decay affect phenotypic variation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M A Nowak,et al.  Quantifying the kinetic parameters of prion replication. , 1999, Biophysical chemistry.

[4]  F. Cohen,et al.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes , 2006, Proceedings of the National Academy of Sciences.

[5]  S. Lindquist,et al.  Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+] , 2009, Nature Structural &Molecular Biology.

[6]  Haijing Yu,et al.  Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae , 2008, Nature Genetics.

[7]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[8]  Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. , 2005 .

[9]  S. Saupe,et al.  Fungal incompatibility: Evolutionary origin in pathogen defense? , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[10]  Christian von Mering,et al.  Expression of Amino-Terminally Truncated PrP in the Mouse Leading to Ataxia and Specific Cerebellar Lesions , 1998, Cell.

[11]  B. Cox,et al.  Ψ, A cytoplasmic suppressor of super-suppressor in yeast , 1965, Heredity.

[12]  D. Shore,et al.  Growth control and ribosome biogenesis. , 2009, Current opinion in cell biology.

[13]  A. Aguzzi,et al.  Normal host prion protein necessary for scrapie-induced neurotoxicity , 1996, Nature.

[14]  J. Collinge,et al.  Species‐barrier‐independent prion replication in apparently resistant species , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[15]  V. Jansen,et al.  Designing drugs to stop the formation of prion aggregates and other amyloids. , 2000, Biophysical chemistry.

[16]  E. Kandel,et al.  A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties , 2003, Cell.

[17]  Christiane Ritter,et al.  The mechanism of prion inhibition by HET-S. , 2010, Molecular cell.

[18]  R. Wickner,et al.  Interactions among prions and prion “strains” in yeast , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  O. King,et al.  A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins , 2009, Cell.

[20]  E. M. Jones,et al.  Fibril Conformation as the Basis of Species- and Strain-Dependent Seeding Specificity of Mammalian Prion Amyloids , 2005, Cell.

[21]  R. Kimberlin,et al.  Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. , 1987, The Journal of general virology.

[22]  H. Radford,et al.  The role of GPI-anchored PrP C in mediating the neurotoxic effect of scrapie prions in neurons. , 2010, Current issues in molecular biology.

[23]  G. Fink,et al.  Frameshifts and frameshift suppressors in Saccharomyces cerevisiae. , 1977, Genetics.

[24]  A. Aguzzi,et al.  High Prion and PrPSc Levels but Delayed Onset of Disease in Scrapie-Inoculated Mice Heterozygous for a Disrupted PrP Gene , 1994, Molecular medicine.

[25]  The mitochondrial genome of yeast Hansenula wingei encodes NADH dehydrogenase subunit genes ND4L and ND5 , 1994, Molecular and General Genetics MGG.

[26]  J. Weissman,et al.  A Critical Role for Amino-Terminal Glutamine/Asparagine Repeats in the Formation and Propagation of a Yeast Prion , 1998, Cell.

[27]  S. Prusiner.  Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[28]  J. Collinge,et al.  Targeting Cellular Prion Protein Reverses Early Cognitive Deficits and Neurophysiological Dysfunction in Prion-Infected Mice , 2007, Neuron.

[29]  L. Manuelidis,et al.  Evolution of a strain of CJD that induces BSE-like plaques. , 1997, Science.

[30]  P. Lansbury,et al.  Predisposition of prion protein homozygotes to Creutzfeldt-Jakob disease can be explained by a nucleation-dependent polymerization mechanism , 1994 .

[31]  G. Jackson,et al.  The role of the cellular prion protein in the immune system , 2006, Clinical and experimental immunology.

[32]  Heather L. True,et al.  Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits , 2004, Nature.

[33]  J. Collinge,et al.  Preventing prion pathogenicity by targeting the cellular prion protein. , 2009, Infectious disorders drug targets.

[34]  J. Weissman,et al.  A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  O. Namy,et al.  Translational readthrough of the PDE2 stop codon modulates cAMP levels in Saccharomyces cerevisiae , 2002, Molecular microbiology.

[36]  M. Tuite,et al.  Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion‐mediated mechanism , 1999, The EMBO journal.

[37]  T. Cooper,et al.  Ure2, a Prion Precursor with Homology to Glutathione S-Transferase, Protects Saccharomyces cerevisiae Cells from Heavy Metal Ion and Oxidant Toxicity* , 2003, The Journal of Biological Chemistry.

[38]  Atanas V Koulov,et al.  Functional Amyloid Formation within Mammalian Tissue , 2005, PLoS biology.

[39]  Suzanne S. Sindi,et al.  Prion dynamics and the quest for the genetic determinant in protein-only inheritance. , 2009, Current opinion in microbiology.

[40]  V. Coustou,et al.  The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  I. Mcconnell,et al.  PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[42]  F. Cohen,et al.  Prion diseases of humans and animals , 1996 .

[43]  Jacob I. Ayers,et al.  Coinfecting Prion Strains Compete for a Limiting Cellular Resource , 2010, Journal of Virology.

[44]  S. Supattapone,et al.  Trans-Dominant Inhibition of Prion Propagation In Vitro Is Not Mediated by an Accessory Cofactor , 2009, PLoS pathogens.

[45]  Y. Chernoff,et al.  Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non‐overlapping functional regions in the encoded protein , 1993, Molecular microbiology.

[46]  D. Walsh,et al.  Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host , 2006, Science.

[47]  A. Aguzzi,et al.  Lethal recessive myelin toxicity of prion protein lacking its central domain , 2007, The EMBO journal.

[48]  Peter Chien,et al.  Emerging principles of conformation-based prion inheritance. , 2004, Annual review of biochemistry.

[49]  Martin Bard,et al.  Mot3 is a transcriptional repressor of ergosterol biosynthetic genes and is required for normal vacuolar function in Saccharomyces cerevisiae , 2002, The EMBO journal.

[50]  K. Volkov,et al.  Non-Mendelian determinant [ISP+] in yeast is a nuclear-residing prion form of the global transcriptional regulator Sfp1 , 2010, Proceedings of the National Academy of Sciences.

[51]  S. Hornemann,et al.  A molecular switch controls interspecies prion disease transmission in mice. , 2010, The Journal of clinical investigation.

[52]  Sebastian Brandner,et al.  Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis , 2003, Science.

[53]  Jonathan S Weissman,et al.  Multiple Gln/Asn-Rich Prion Domains Confer Susceptibility to Induction of the Yeast [PSI+] Prion , 2001, Cell.

[54]  H. Fraser,et al.  Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. , 1968, Journal of comparative pathology.

[55]  G. Raposo,et al.  Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis , 2003, The Journal of cell biology.

[56]  R. Wickner,et al.  Yeast prions [URE3] and [PSI+] are diseases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[57]  F. Cohen,et al.  Dominant-negative inhibition of prion replication in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Prusiner,et al.  Distinct prion proteins in short and long scrapie incubation period mice , 1987, Cell.

[59]  J. Griffith,et al.  Self-replication and scrapie. , 1967, Nature.

[60]  D. Taylor,et al.  Extraneural competition between different scrapie agents leading to loss of infectivity , 1975, Nature.

[61]  A. Aguzzi,et al.  The prion's elusive reason for being. , 2008, Annual review of neuroscience.

[62]  M. Laurent.  Bistability and the species barrier in prion diseases: stepping across the threshold or not. , 1998, Biophysical chemistry.

[63]  I. Pattison,et al.  Modification of a strain of mouse-adapted scrapie by passage through rats. , 1968, Research in veterinary science.

[64]  N. Hunter,et al.  PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. , 1994, The Journal of general virology.

[65]  R. Wickner,et al.  [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. , 1994, Science.

[66]  Y. Chernoff,et al.  Genetic and epigenetic control of the efficiency and fidelity of cross‐species prion transmission , 2010, Molecular microbiology.

[67]  J. Collinge,et al.  Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease , 2008, Proceedings of the National Academy of Sciences.

[68]  Ronald Melki,et al.  Prion-like transmission of protein aggregates in neurodegenerative diseases , 2010, Nature Reviews Molecular Cell Biology.

[69]  M. Kirkpatrick,et al.  Effects of the [PSI+] prion on rates of adaptation in yeast , 2008, Journal of evolutionary biology.

[70]  S. Liebman,et al.  The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion , 2009, Nature Cell Biology.

[71]  J. Aiken,et al.  Adaptation and Selection of Prion Protein Strain Conformations following Interspecies Transmission of Transmissible Mink Encephalopathy , 2000, Journal of Virology.

[72]  S. Saupe.  A Short History of Small s , 2007, Prion.

[73]  Eric D Ross,et al.  Primary sequence independence for prion formation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[74]  B. Chesebro,et al.  Scrapie infectivity found in resistant species , 1998, Nature.

[75]  S. Paushkin,et al.  Propagation of the yeast prion‐like [psi+] determinant is mediated by oligomerization of the SUP35‐encoded polypeptide chain release factor. , 1996, The EMBO journal.

[76]  J. Foster,et al.  The unusual properties of CH1641, a sheep-passaged isolate of scrapie , 1988, Veterinary Record.

[77]  C. Gibbs,et al.  SLOW, LATENT AND TEMPERATE VIRUS INFECTIONS , 1967 .

[78]  Jonathan S Weissman,et al.  Dissection and Design of Yeast Prions , 2004, PLoS biology.

[79]  Ian A. Williams,et al.  Genome-wide prediction of stop codon readthrough during translation in the yeast Saccharomyces cerevisiae. , 2004, Nucleic acids research.

[80]  R. Kopito,et al.  Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates , 2009, Nature Cell Biology.

[81]  J. Langeveld,et al.  Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. , 2009, Brain : a journal of neurology.

[82]  S. Prusiner,et al.  Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. , 1994, Genes & development.

[83]  B. Caughey,et al.  Molecular heterosis of prion protein beta-oligomers. A potential mechanism of human resistance to disease. , 2006, The Journal of biological chemistry.

[84]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[85]  R Andhare,et al.  Nitrogen Catabolite Repression of DAL80Expression Depends on the Relative Levels of Gat1p and Ure2p Production in Saccharomyces cerevisiae * , 2000, The Journal of Biological Chemistry.

[86]  H. Fraser,et al.  The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. , 1989, The Journal of general virology.

[87]  J. Griffith,et al.  Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.

[88]  M. Tuite,et al.  Mechanism of inhibition of Ψ+ prion determinant propagation by a mutation of the N‐terminus of the yeast Sup35 protein , 1998, The EMBO journal.

[89]  Charles Weissmann,et al.  Darwinian Evolution of Prions in Cell Culture , 2010, Science.

[90]  B. Magasanik,et al.  Regulation of nitrogen assimilation in Saccharomyces cerevisiae: roles of the URE2 and GLN3 genes , 1988, Journal of bacteriology.

[91]  T. Crow,et al.  Codon 129 changes in the prion protein gene in Caucasians. , 1990, American journal of human genetics.

[92]  A. Aguzzi.  Cell biology: Beyond the prion principle , 2009, Nature.

[93]  R. Marsh,et al.  Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. , 1992, The Journal of general virology.

[94]  F. Cohen,et al.  Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[95]  P. Simioni,et al.  AN UPDATED CLASSIFICATION OF FACTOR XIII DEFECT , 1991, British journal of haematology.

[96]  Andrew D. Steele,et al.  The Prion Protein Knockout Mouse , 2007, Prion.

[97]  M. Maddelein,et al.  A non-Q/N-rich prion domain of a foreign prion, [Het-s], can propagate as a prion in yeast. , 2007, Molecular cell.

[98]  G. Bernardi.  Lessons from a small, dispensable genome: the mitochondrial genome of yeast. , 2005, Gene.

[99]  R. Shin,et al.  Codon 219 lys allele of PRNP is not found in sporadic Creutzfeldt‐Jakob disease , 1998, Annals of neurology.

[100]  D. Harris,et al.  The cellular prion protein (PrP(C)): its physiological function and role in disease. , 2007, Biochimica et biophysica acta.

[101]  B. Cox,et al.  Extrachromosomal elements in a super-suppression system of yeast I. A nuclear gene controlling the inheritance of the extrachromosomal elements , 1971, Heredity.

[102]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[103]  I. Derkatch,et al.  Distinct Type of Transmission Barrier Revealed by Study of Multiple Prion Determinants of Rnq1 , 2010, PLoS genetics.

[104]  C. King,et al.  Supporting the structural basis of prion strains: induction and identification of [PSI] variants. , 2001, Journal of molecular biology.

[105]  H. True,et al.  A yeast prion provides a mechanism for genetic variation and phenotypic diversity , 2000, Nature.

[106]  R. Eckroade,et al.  A preliminary report on the experimental host range of the transmissible mink encephalopathy agent. , 1969, The Journal of infectious diseases.

[107]  E. Masliah,et al.  Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie , 2005, Science.

[108]  J. Castilla,et al.  Prion Strain Mutation Determined by Prion Protein Conformational Compatibility and Primary Structure , 2010, Science.

[109]  C. Glabe.  Common mechanisms of amyloid oligomer pathogenesis in degenerative disease , 2006, Neurobiology of Aging.

[110]  Yoshikazu Nakamura,et al.  Yeast [PSI+] "prions" that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. , 2001, Molecular cell.

[111]  C. Nierras,et al.  The dominant PNM2- mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. , 1994, Genetics.

[112]  Stanley B. Prusiner,et al.  Slow transmissible diseases of the nervous system , 1979 .

[113]  Jonathan S. Weissman,et al.  The physical basis of how prion conformations determine strain phenotypes , 2006, Nature.

[114]  H. Fraser,et al.  Scrapie incubation time can exceed natural lifespan , 1975, Nature.

[115]  Stephen J. DeArmond,et al.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.

[116]  Christopher M. Dobson,et al.  Molecular recycling within amyloid fibrils , 2005, Nature.

[117]  N. Makarava,et al.  Conformational Switching within Individual Amyloid Fibrils* , 2009, Journal of Biological Chemistry.

[118]  S. Liebman,et al.  Prions Affect the Appearance of Other Prions The Story of [PIN+] , 2001, Cell.

[119]  B. Ghetti,et al.  Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification , 2009, Acta Neuropathologica.

[120]  John Collinge,et al.  A General Model of Prion Strains and Their Pathogenicity , 2007, Science.

[121]  R. Wickner,et al.  A prion of yeast metacaspase homolog (Mca1p) detected by a genetic screen , 2009, Proceedings of the National Academy of Sciences.

[122]  R. Kimberlin,et al.  Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. , 1978, The Journal of general virology.

[123]  J. Collinge,et al.  The Residue 129 Polymorphism in Human Prion Protein Does Not Confer Susceptibility to Creutzfeldt-Jakob Disease by Altering the Structure or Global Stability of PrPC* , 2004, Journal of Biological Chemistry.

[124]  H. Fraser,et al.  Competition between different scrapie agents in mice. , 1972, Nature: New biology.

[125]  David Eisenberg,et al.  In Brief , 2009, Nature Reviews Neuroscience.

[126]  H. Kretzschmar,et al.  Breaking an Absolute Species Barrier: Transgenic Mice Expressing the Mink PrP Gene Are Susceptible to Transmissible Mink Encephalopathy , 2005, Journal of Virology.

[127]  S. Lindquist,et al.  Rnq 1 : An Epigenetic Modifier of Protein , 2000 .

[128]  R. Wickner,et al.  Prion Variants and Species Barriers Among Saccharomyces Ure2 Proteins , 2009, Genetics.

[129]  S. Lindquist,et al.  Prion protein gene polymorphisms in Saccharomyces cerevisiae , 2003, Molecular microbiology.

[130]  S. Liebman,et al.  Dependence and independence of [PSI+] and [PIN+]: a two‐prion system in yeast? , 2000, The EMBO journal.

[131]  K. Abid,et al.  The prion strain phenomenon: molecular basis and unprecedented features. , 2007, Biochimica et biophysica acta.

[132]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[133]  R. J. Harris.  Slow Virus Diseases of Animals and Man , 1976 .

[134]  Tobias Haslberger,et al.  Towards a unifying mechanism for ClpB/Hsp104-mediated protein disaggregation and prion propagation. , 2010, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[135]  Jae-Il Kim,et al.  Association of sporadic Creutzfeldt–Jakob disease with homozygous genotypes at PRNP codons 129 and 219 in the Korean population , 2005, Neurogenetics.

[136]  W. Surewicz,et al.  Molecular basis of barriers for interspecies transmissibility of mammalian prions. , 2004, Molecular cell.

[137]  J. Masel,et al.  Complex Adaptations Can Drive the Evolution of the Capacitor [PSI +], Even with Realistic Rates of Yeast Sex , 2009, PLoS genetics.

[138]  R. Glockshuber,et al.  Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. , 1999, Biochemistry.

[139]  D. Cheresh.  URE 3 ] as an Altered URE 2 Protein : Evidence for a Prion Analog in Saccharomyces cerevisiae , 2022 .

[140]  J R Glover,et al.  Support for the Prion Hypothesis for Inheritance of a Phenotypic Trait in Yeast , 1996, Science.

[141]  F. Cohen,et al.  Pathway Complexity of Prion Protein Assembly into Amyloid* , 2002, The Journal of Biological Chemistry.

[142]  R. Nixon,et al.  Sniffing out a function for prion proteins , 2009, Nature Neuroscience.

[143]  Beat Meier,et al.  Prions , 2010 .

[144]  L. Luncz,et al.  Regulation of Embryonic Cell Adhesion by the Prion Protein , 2009, PLoS biology.

[145]  R. Hoekstra,et al.  Sexual transmission of the [Het-s] prion leads to meiotic drive in Podospora anserina , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[146]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[147]  I. Baskakov,et al.  The dominant‐negative effect of the Q218K variant of the prion protein does not require protein X , 2007, Protein science : a publication of the Protein Society.

[148]  P. Zhou,et al.  The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast , 1999, Current Genetics.

[149]  O. Namy,et al.  Epigenetic control of polyamines by the prion [PSI+] , 2008, Nature Cell Biology.

[150]  P. Disterer,et al.  Methionine 129 Variant of Human Prion Protein Oligomerizes More Rapidly than the Valine 129 Variant , 2004, Journal of Biological Chemistry.

[151]  S. Prusiner,et al.  Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant Prions , 2009, PLoS pathogens.

[152]  Matthew R Chapman,et al.  Curli biogenesis and function. , 2006, Annual review of microbiology.

[153]  R. Wickner,et al.  Prions of fungi: inherited structures and biological roles , 2007, Nature Reviews Microbiology.

[154]  Y. Chernoff,et al.  Prion species barrier between the closely related yeast proteins is detected despite coaggregation , 2007, Proceedings of the National Academy of Sciences.

[155]  Eric R. Kandel,et al.  Aplysia CPEB Can Form Prion-like Multimers in Sensory Neurons that Contribute to Long-Term Facilitation , 2010, Cell.

[156]  Andrew D. Steele,et al.  A Phenotype Under Challenge , 2007 .

[157]  M. Tuite,et al.  Chaperoning prions: the cellular machinery for propagating an infectious protein? , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[158]  K. Hofmann,et al.  Polyamines regulate their synthesis by inducing expression and blocking degradation of ODC antizyme. , 2004, The EMBO journal.

[159]  Frank Baumann,et al.  Axonal prion protein is required for peripheral myelin maintenance , 2010, Nature Neuroscience.

[160]  S. Lindquist,et al.  Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[161]  I. Zlotnik,et al.  EXPERIMENTAL TRANSMISSION OF MOUSE PASSAGED SCRAPIE TO GOATS, SHEEP, RATS AND HAMSTERS. , 1965, Journal of comparative pathology.